HS
HighVista Strategies’s Apellis Pharmaceuticals APLS Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.5M | Sell |
86,663
-22,051
| -20% | -$382K | 0.55% | 65 |
|
|
2025
Q1 | $2.38M | Hold |
108,714
| – | – | 0.92% | 22 |
|
|
2024
Q4 | $3.47M | Buy |
108,714
+72,739
| +202% | +$2.32M | 1.29% | 14 |
|
|
2024
Q3 | $1.04M | Buy |
35,975
+28,409
| +375% | +$819K | 0.36% | 101 |
|
|
2024
Q2 | $290K | Buy |
7,566
+300
| +4% | +$11.5K | 0.11% | 135 |
|
|
2024
Q1 | $427K | Buy |
+7,266
| New | +$427K | 0.15% | 124 |
|
|
2023
Q3 | – | Sell |
-30,242
| Closed | -$2.76M | – | 136 |
|
|
2023
Q2 | $2.76M | Sell |
30,242
-8,869
| -23% | -$808K | 1.26% | 21 |
|
|
2023
Q1 | $2.58M | Hold |
39,111
| – | – | 2.1% | 13 |
|
|
2022
Q4 | $2.02M | Sell |
39,111
-14,431
| -27% | -$746K | 1.2% | 28 |
|
|
2022
Q3 | $3.66M | Buy |
53,542
+7,401
| +16% | +$506K | 2.09% | 11 |
|
|
2022
Q2 | $2.09M | Buy |
46,141
+9,248
| +25% | +$418K | 1.26% | 25 |
|
|
2022
Q1 | $1.88M | Buy |
+36,893
| New | +$1.88M | 1.19% | 24 |
|
|
2021
Q4 | – | Sell |
-19,763
| Closed | -$651K | – | 72 |
|
|
2021
Q3 | $651K | Buy |
+19,763
| New | +$651K | 0.43% | 64 |
|